Rockwell Medical Inc (RMTI)

2.98 +0.05  +1.71% NASDAQ Feb 28, 16:59 Delayed 2m USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
03/13/2020 08:30 EDT Misc Rockwell Medical Inc Fourth Quarter Earnings Conference Call in 2019
03/13/2020 Earnings Rockwell Medical Inc Fourth Quarter Earnings in 2019 Release
11/11/2019 16:30 EST Misc Rockwell Medical Inc Third Quarter Earnings Conference Call for 2019
11/11/2019 Earnings Rockwell Medical Inc Third Quarter Earnings in 2019 Release
08/08/2019 16:30 EDT Misc Rockwell Medical Inc Second Quarter Earnings Conference Call in 2019
08/08/2019 Earnings Rockwell Medical Inc Second Quarter Earnings in 2019 Release
06/06/2019 10:00 EDT Misc Rockwell Medical Inc Annual General Meeting in 2018
05/09/2019 16:30 EDT Misc Rockwell Medical Inc First Quarter Earnings Conference Call in 2019
05/09/2019 Earnings Rockwell Medical Inc First Quarter Earnings in 2019 Release
03/18/2019 Misc Rockwell Medical Inc Annual Report in 2018
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: http://www.rockwellmed.com
  • Investor Relations URL: http://ir.rockwellmed.com/
  • HQ State/Province: Michigan
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Specialty & Generic
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Mar. 13, 2020
  • Last Earnings Release: Nov. 11, 2019
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Rockwell Medical Inc is a US-based fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease with its products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The company's drug products are Triferic and Calcitriol. Triferic is a therapy indicated to replace iron and maintain hemoglobin in adult hemodialysis patients with chronic kidney disease. It replaces the ongoing iron loss that occurs to patients during every hemodialysis treatment, via dialysate. Calcitriol is a generic drug for treating secondary hyperparathyroidism in dialysis patients. The company operates in one segment of hemodialysis market which involves the manufacture, sale, and distribution of hemodialysis products.

Top Fund Holders

Symbol Name Weighting
PDFDX Perkins Discovery 1.23%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.